PCA(P)(2024)33 - Extension to Serious Shortage Protocols for Ramipril 2.5mg Tablets and Creon® Gastro-resistant Capsules
Published: 21/11/24
Introduction
This Circular advises Health Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for ramipril 2.5mg tablets (SSP 071) due to expire on 15 November 2024 has been extended until Friday 29 November 2024.
In addition, the two UK-wide SSPs for Creon® 10000 gastro-resistant capsules (SSP060) and Creon® 25000 gastro-resistant capsules (SSP061) both due to expire on 22 November 2024 have been extended until Friday 23 May 2025.
Community pharmacists are advised to review and familiarise themselves with the new end dates for the above noted SSPs.
Background
To assist in alleviating current supply issues with medicines availability, various UK-wide SSPs have been issued by the Department of Health and Social Care (DHSC), in consultation with the Scottish Government. An SSP is an additional tool to manage and mitigate medication shortages for prescribing clinicians, community pharmacies and importantly patients.
Each SSP is individually developed and authorised clinically, to enable community pharmacists and dispensing doctors to dispense a different strength or formulation or alternative medicine or appliances in accordance with the protocol, rather than having to refer prescribing decisions back to the original prescriber. These protocols are time limited.
Community pharmacists are expected to use their professional skill and judgement to decide whether it is reasonable and appropriate to substitute a person's prescribed medicine using the SSP. The person will also have to agree to the alternative supply.
The DHSC frequently reviews which medicines should be under an SSP and for how long they need to be in place.
Any amendments or extensions to existing SSPs are documented on the NHS Business Services Authority website using the following link: Serious shortage protocols (SSPs) | NHSBSA.
